The authority examined whether plastic filter tips used with automated instruments were machine parts and held they were disposable consumables, classifiable as articles of plastic under CTH ...

The High Court rejected bail after holding that the slogan used by the crowd challenged the authority of law and sovereignty of India. The ruling emphasises that calls for violence fall outside ...

Matthew is a writer for Game Rant. His first console was the NES, but he made most of his childhood memories with the SNES. Matthew spent much of his early life begging to go to Blockbuster to browse ...

Apple has officially released iOS 26.2 for iPhone. The latest version includes Liquid Glass design tweaks, new customization options for CarPlay, and much more. Today’s release is available for all ...

Abyss has been added to the core game. You can find Abyss encounters in specific campaign areas, starting in Act 2. Abyss encounters have been added to the Endgame, as well as Abyss Tablets and ...

Nintendo has released its latest system software update for the Switch and Switch 2, bringing both consoles' firmware up to Version 21.1.0. Today's patch is a minor one — at least, according to the ...

Following a firmware update for the Switch 2 and Switch in November, Nintendo has now rolled out a December update (and what could potentially be the final system update of the year). According to the ...

Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

There have been so many announcements and game releases recently, and to add to this, Pokémon Legends: Z-A's Mega Dimension DLC is out this week. Now, as part of the arrival of this new content, ...

Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...